For the period January 2016 to March 2016, a total of 111 samples were submitted to the WRLFMD for FMDV detection and serotyping from Ethiopia, Hong Kong, SAR of PRC, Israel, Republic of Korea, Kuwait, Nepal, Palestinian Autonomous Territories, Saudi Arabia and United Arab Emirates.

Testing was also completed on 118 samples from Iran, Pakistan, Sudan and Thailand that were received in the October to December 2015 period.